Ampersand Capital and 1315 Capital to acquire Genoptix's commercial lab

Ampersand Capital Partners and 1315 Capital have agreed to acquire Genoptix's commercial laboratory. No financial terms were disclosed for the transaction that is being done in partnership with a management group led by Joseph M. Limber. The deal is expected to close in the first quarter of this year. Based in Carlsbad, California, Genoptix is a hematopathology center.

DealsNorth AmericaUSBriefs